Edwards Lifesciences (BSP:E1WL34) Cyclically Adjusted Book per Share: R$13.38 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:E1WL34 Edwards Lifesciences Corp BSP:E1WL34
91 GF Score
Price R$105.71
GF Value R$115.67
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Edwards Lifesciences Cyclically Adjusted Book per Share?

Edwards Lifesciences BSP:E1WL34 91 Cyclically Adjusted Book per Share is R$13.38 as of Mar. 2026. GuruFocus rates BSP:E1WL34 with a GF Score™ of 91/100 and a GF Value™ of R$115.67 (Modestly Undervalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Edwards Lifesciences's adjusted book value per share for the three months ended in Mar. 2026 was R$23.401. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is R$13.38 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Edwards Lifesciences's average Cyclically Adjusted Book Growth Rate was 18.00% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 17.20% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 18.40% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 17.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Edwards Lifesciences was 19.30% per year. The lowest was 11.30% per year. And the median was 15.25% per year.

As of today (2026-08-01), Edwards Lifesciences's current stock price is R$105.71. Edwards Lifesciences's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was R$13.38. Edwards Lifesciences's Cyclically Adjusted PB Ratio of today is 7.90.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Edwards Lifesciences was 26.56. The lowest was 7.52. And the median was 15.12.


Edwards Lifesciences  (BSP:E1WL34) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Edwards Lifesciences's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=105.71/13.38
=7.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Edwards Lifesciences was 26.56. The lowest was 7.52. And the median was 15.12.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Edwards Lifesciences Cyclically Adjusted Book per Share Related Terms


Edwards Lifesciences Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Edwards Lifesciences's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Edwards Lifesciences Cyclically Adjusted Book per Share Chart

Edwards Lifesciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.21 8.11 8.65 12.98 13.71

Edwards Lifesciences Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.48 12.71 13.71 13.38 0.00

BSP:E1WL34 vs BSX, DXCM, GEHC: Cyclically Adjusted Book per Share Comparison

For the Medical Devices subindustry, Edwards Lifesciences's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Edwards Lifesciences Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Edwards Lifesciences's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Edwards Lifesciences's Cyclically Adjusted PB Ratio falls into.


BSP:E1WL34
91GF Score
Edwards Lifesciences Corp BSP:E1WL34
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Edwards Lifesciences Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Edwards Lifesciences's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=23.401/330.2130*330.2130
=23.401

Current CPI (Mar. 2026) = 330.2130.

Edwards Lifesciences Quarterly Data

Book Value per Share CPI Adj_Book
201606 3.314 241.018 4.540
201609 3.415 241.428 4.671
201612 3.459 241.432 4.731
201703 3.397 243.801 4.601
201706 3.824 244.955 5.155
201709 3.901 246.819 5.219
201712 3.871 246.524 5.185
201803 4.209 249.554 5.569
201806 4.753 251.989 6.228
201809 5.504 252.439 7.200
201812 4.893 251.233 6.431
201903 5.295 254.202 6.878
201906 5.410 256.143 6.974
201909 6.281 256.759 8.078
201912 6.786 256.974 8.720
202003 7.692 258.115 9.841
202006 8.014 257.797 10.265
202009 9.125 260.280 11.577
202012 9.424 260.474 11.947
202103 10.554 264.877 13.157
202106 10.357 271.696 12.588
202109 11.716 274.310 14.104
202112 13.220 278.802 15.658
202203 11.702 287.504 13.440
202206 12.101 296.311 13.486
202209 13.159 296.808 14.640
202212 12.518 296.797 13.927
202303 12.845 301.836 14.053
202306 12.726 305.109 13.773
202309 13.553 307.789 14.540
202312 13.552 306.746 14.589
202403 14.710 312.332 15.552
202406 16.627 314.175 17.476
202409 22.407 315.301 23.467
202412 25.909 315.605 27.108
202503 24.873 319.799 25.683
202506 24.869 322.561 25.459
202509 23.562 324.800 23.955
202512 24.281 324.054 24.742
202603 23.401 330.213 23.401

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of R$13.38 mean?
Edwards Lifesciences (BSP:E1WL34) has a Cyclically Adjusted Book per Share of R$13.38 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Edwards Lifesciences and its competitors.
Is Edwards Lifesciences' Cyclically Adjusted Book per Share too high?
Edwards Lifesciences' current Cyclically Adjusted Book per Share is R$13.38. Overall, Edwards Lifesciences has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Edwards Lifesciences' Cyclically Adjusted Book per Share compare to BSX and DXCM?
Edwards Lifesciences' Cyclically Adjusted Book per Share of R$13.38 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Book per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Edwards Lifesciences and its competitors. Edwards Lifesciences's current Cyclically Adjusted Book per Share is R$13.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Edwards Lifesciences stock overvalued right now?
Based on GuruFocus' analysis, Edwards Lifesciences (BSP:E1WL34) is currently considered Modestly Undervalued. The stock's GF Value™ is R$115.67, compared to a current price of R$105.71 — trading 8.6% below its estimated fair value. The current Cyclically Adjusted Book per Share is R$13.38. Edwards Lifesciences' overall GF Score™ is 91/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Edwards Lifesciences (BSP:E1WL34), the current Cyclically Adjusted Book per Share is R$13.38 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Edwards Lifesciences (BSP:E1WL34) Overvalued in 2026?

Based on GuruFocus' analysis, Edwards Lifesciences stock appears to be undervalued. The current stock price of R$105.71 is trading 8.6% below its estimated GF Value™ of R$115.67. GuruFocus considers Edwards Lifesciences to be Modestly Undervalued.

Key valuation signals for BSP:E1WL34:

  • Cyclically Adjusted Book per Share: R$13.38
  • GF Value™: R$115.67 vs. price of R$105.71 (8.6% below fair value)
  • GF Score™: 91/100 with 5 warning signs

No single metric tells the full story. See the BSP:E1WL34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Edwards Lifesciences Business Description

Address One Edwards Way, Irvine, CA, USA, 92614
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
91GF Score

Get the complete analysis for BSP:E1WL34

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$105.71
Price
R$115.67
GF Value